These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2439910)

  • 1. Maternal alpha-fetoprotein screening for Down's syndrome.
    Pueschel SM
    N Engl J Med; 1987 Aug; 317(6):376-8. PubMed ID: 2439910
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving methods of screening for Down's syndrome.
    White I; Papiha SS; Magnay D
    N Engl J Med; 1989 Feb; 320(6):401-2. PubMed ID: 2464139
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current techniques of prenatal screening for Down syndrome.
    Cardwell MS; Gay JW
    Mo Med; 1990 May; 87(5):295-7. PubMed ID: 1694954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for Down's syndrome.
    N Engl J Med; 1988 Apr; 318(14):926-9. PubMed ID: 2451130
    [No Abstract]   [Full Text] [Related]  

  • 11. Cautions about maternal serum alpha-fetoprotein screening.
    Milunsky A; Haddow JE
    N Engl J Med; 1985 Sep; 313(11):694. PubMed ID: 2410789
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal serum alpha-fetoprotein screening and Down's syndrome.
    Wu LR
    Am J Obstet Gynecol; 1986 Dec; 155(6):1362-3. PubMed ID: 2431621
    [No Abstract]   [Full Text] [Related]  

  • 13. 46,XY,i(21q) identified by maternal serum screening.
    Meyers CM; Ghori S; Roberson AE; Blitzer MG; Cohen MM
    Md Med J; 1997 Feb; 46(2):88-9. PubMed ID: 9029908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alpha-fetoprotein radioimmunoassay for use in maternal serum screening for Down's syndrome: limitations and improvements.
    Mooney RA; McGorty BL; French CA; Arvan DA
    Clin Chim Acta; 1988 Feb; 171(2-3):325-31. PubMed ID: 2453312
    [No Abstract]   [Full Text] [Related]  

  • 15. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
    Liao S; Wang Y; Ye G
    Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Down's syndrome using an iso-risk curve based on maternal age and serum alpha-fetoprotein level.
    Tabor A; Larsen SO; Nielsen J; Nielsen J; Philip J; Pilgaard B; Videbech P; Nørgaard-Pedersen B
    Br J Obstet Gynaecol; 1987 Jul; 94(7):636-42. PubMed ID: 2441737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of structural abnormalities.
    Sanders RC
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):259-65. PubMed ID: 1717021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low maternal serum alpha-fetoprotein at 10 weeks gestation and fetal Down's syndrome.
    Mantingh A; Marrink J; de Wolf B; Breed AS; Beekhuis JR; Visser GH
    Br J Obstet Gynaecol; 1989 Apr; 96(4):499-500. PubMed ID: 2473774
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doubts using family history, age, alpha-fetoprotein and total human chorionic gonadotrophin in screening for Down's syndrome.
    Ogueh O
    Br J Obstet Gynaecol; 1995 Apr; 102(4):349-50. PubMed ID: 7542022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.